UCSF Spinout Calithera Biosciences Takes $40 Million First Round

The cancer-fighting drug researcher is developing methods of activating caspases, enzymes that induce programmed cell death.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet